Furthermore, endogenous opioid receptors (OR) (i.e., delta (DOR), mu (MOR), kappa (KOR), and nociceptin/orphanin FQ (NOP), which are involved in reward processing and mood control, may also be putative targets for treating MDD [12], [13], [14]. Here, YY1 is linked to major depressive disorder.